The presentation given by Dr. Anna Laromaine at the symposium of the Chemical Biology group in the XXXIV Reunión Bienal de la Real Sociedad de Química was selected as the best flash presentation. Presentation was entitled Biological evaluation of nanoparticles using Bacterial Cellulose films.
Anna will give a talk on BIOLOGICAL ASSESSMENT OF NANOPARTICLES USING BACTERIAL CELLULOSE FILMS within the QUÍMICA EN LA FRONTERA CON LA BIOLOGÍASymposium
The International Sol-Gel Conference will be held in Madrid the coming week. The N&N group will be represented by Nerea, Muling and Pengfei. Nerea will give a talk.
The Joint European Magnetic Symposia will be held in Rhodes, Greece next week. Anna Roig will give an invited talk in Symposium 8 on Medical, Biomedical, Biomagnetic and Biotechnology applications.
First published results on the electrochemichal sensor for heavy metals project as a part of the PhD thesis of Pengfei that is co-supervised by Martí Gich of our group and Cesar Fernandez-Sanchez of the CNM-CSIC
Facile Synthesis of Porous Bismuth-Carbon Nanocomposites for the Sensitive Detection of Heavy Metals Marti Gich, Cesar Fernandez-Sanchez, Liviu Cosmin Cotet, Pengfei Niu and Anna Roig
J. Mater. Chem. A, 2013, Accepted Manuscript DOI: 10.1039/C3TA12190A, Paper
MAGNET, the cooperation project with the Institut de Recerca de la Vall d’Hebron (VHIR) has been selected as one of the five finalists of the prestigious Innovation Prize. Dr. Anna Rosell, that leads this project at the Neurovacular Research Group, will defend it in Paris on the 12th of September. We wish her best luck!
If you want to read more: “El VHIR patenta una teràpia per potenciar la neuroreparació després de l’ictus”
Magnet – Vall d’Hebron Research Institute – Anna Rosell Stroke is a leading cause of death and disability worldwide and neurorepair strategies with advanced cell therapies may become a reality soon. However, this can only be accomplished by achieving the control over the delivery and engraftment of functional cells. The concept of the Magnet therapy is that by labelling endothelial progenitor cells (EPCs) and nanocapsules containing EPCs-growth factors with biocompatible magnetic iron oxide nanoparticles, we will be able to guide their delivery to precise brain areas by externally applying a magnetic field force to enhance neurorepair and recovery.
The techonology is patented and we are currently in search of a company interested in lincense it. Publication of the firsts results can be found in the paper “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies”
Figure: Image of an endothelial progenitor cell (EPC) taken with a Transmission Soft cryo-X-ray Microscopy from the ALBA Synchroton.
Carles Rubio has just finished the third year of Nanoscience and Nanotechnology degree in the UAB. This summer, he will work in the synthesis of iron oxide with metalic dopping under the supervision of Marti Gich.